Stay updated on Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF
Sign up to get notified when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.

Latest updates to the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 has been added and Revision: v3.4.1 has been removed. This is an internal version update with no changes to study details, endpoints, or user-facing content.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.4.1 has been added and Revision: v3.4.0 has been removed.SummaryDifference0.0%

- Check47 days agoChange DetectedGlossary display feature added; footer updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This appears to be a technical update without changes to study details on the page.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations section was updated to include many new study sites across multiple regions (US states, Canada, UK, Australia, and other areas). The HHS Vulnerability Disclosure item was removed.SummaryDifference1%

Stay in the know with updates to Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF
Enter your email address, and we'll notify you when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.